These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6214868)

  • 41. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
    Cofrancesco E; Colombi M; Gianese F; Cortellaro M
    Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disappearance of human platelet factor 4 (PF4) in rabbits: does an immediate component exist?
    Prosdocimi M; Scattolo N; Mazzucato A; Zatta A; Fabris F; Girolami A; Cella G
    Thromb Res; 1985 Sep; 39(5):541-7. PubMed ID: 4082099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serial studies of platelet factor 4 and beta thromboglobulin during exercise in patients with coronary artery disease.
    Strauss WE; Cella G; Parisi AF; Sasahara AA
    Am Heart J; 1985 Aug; 110(2):293-9. PubMed ID: 2411121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A formula for correcting for the in vitro release of platelet beta-thromboglobulin.
    van Wyk V; Heyns AD; de Wet JI; Kotzé HF; Lötter MG
    Thromb Res; 1987 Jun; 46(5):659-68. PubMed ID: 2957816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human platelet factor 4 and protamine sulphate interaction with glycosaminoglycans in the rabbit.
    Cella G; Myers CJ; Prosdocimi M; Sasahara AA
    Eur J Clin Invest; 1987 Dec; 17(6):548-54. PubMed ID: 3123254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet markers of thromboembolic disease.
    Wohl H
    West J Med; 1981 Jul; 135(1):19-24. PubMed ID: 6167074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation.
    Bastl CP; Musial J; Kloczewiak M; Guzzo J; Berman I; Niewiarowski S
    Blood; 1981 Feb; 57(2):233-8. PubMed ID: 6160892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protease-induced immunoregulatory activity of platelet factor 4.
    Katz IR; Thorbecke GJ; Bell MK; Yin JZ; Clarke D; Zucker MB
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3491-5. PubMed ID: 3517862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma levels of platelet factor 4 measured by radioimmunoassay.
    Chesterman CN; McGready JR; Doyle DJ; Morgan FJ
    Br J Haematol; 1978 Nov; 40(3):489-500. PubMed ID: 749930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemodynamic and platelet response to the bolus intravenous administration of porcine heparin.
    Bjoraker DG; Ketcham TR
    Thromb Haemost; 1983 Feb; 49(1):1-4. PubMed ID: 6221433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-thromboglobulin (beta tg) and platelet factor 4 (PF4) in patients with myeloproliferative diseases.
    Fabris F; Luzzatto G; Randi ML; Cella G
    Thromb Haemost; 1994 Sep; 72(3):484-6. PubMed ID: 7710537
    [No Abstract]   [Full Text] [Related]  

  • 54. Prostacyclin and iloprost do not affect action of standard dose heparin on haemostatic function during haemodialysis.
    Dibble JB; Kalra PA; Orchard MA; Turney JH; Davies JA
    Thromb Res; 1988 Feb; 49(4):385-92. PubMed ID: 2454514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Standardization of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4): a collaborative study to establish international standards for beta-TG and PF4.
    Kerry PJ; Curtis AD
    Thromb Haemost; 1985 Feb; 53(1):51-5. PubMed ID: 2581331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Plasma beta-thromboglobulin level in thromboembolic diseases: a marker of in-vivo platelet release reaction].
    Modiano A
    G Clin Med; 1980 Sep; 61(9):672-8. PubMed ID: 6162700
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of platelet factor 4 (PF4) on assays of plasma heparin.
    Levine SP; Sorenson RR; Harris MA; Knieriem LK
    Br J Haematol; 1984 Aug; 57(4):585-96. PubMed ID: 6743573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin.
    Rucinski B; Knight LC; Niewiarowski S
    Am J Physiol; 1986 Oct; 251(4 Pt 2):H800-7. PubMed ID: 3766757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of in vivo platelet activation in uncomplicated essential hypertension.
    Guicheney P; Baudouin-Legros M; Meyer P
    Life Sci; 1987 Feb; 40(7):615-21. PubMed ID: 2949131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
    Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
    Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.